241 related articles for article (PubMed ID: 27664106)
1. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
2. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.
Zheng F; Gu Y; Zha H; Deng J; Zhang Z
Mycopathologia; 2017 Jun; 182(5-6):555-560. PubMed ID: 27928649
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
5. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
Zeng SY; Liu T; Meng WT; Chen YN
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
[TBL] [Abstract][Full Text] [Related]
6. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
7. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
9. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
11. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
13. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
[TBL] [Abstract][Full Text] [Related]
16. Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.
Lo Cascio G; Koncan R; Stringari G; Russo A; Azzini A; Ugolini A; Ligozzi M; Polati E; Cornaglia G; Concia E; Schweiger V
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):357-65. PubMed ID: 25217227
[TBL] [Abstract][Full Text] [Related]
17. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of plasma (1, 3)-beta-D glucan assay for invasive fungal infections in patients with hematological disorders].
Liu F; Wu T; Cai P; Liu Y; Lu Y; Zhou JR; Yang F; Liu Q; Gao YQ; Luo RM; Zhang JP; Sun Y; Cao XY; Yin YM; Zhao YL; Wang JB; Tong CR; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1043-6. PubMed ID: 19698256
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.
Senn L; Robinson JO; Schmidt S; Knaup M; Asahi N; Satomura S; Matsuura S; Duvoisin B; Bille J; Calandra T; Marchetti O
Clin Infect Dis; 2008 Mar; 46(6):878-85. PubMed ID: 18260755
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of serum galactomannan and β-D-glucan for invasive aspergillosis in suspected patients: A meta-analysis.
Huang QY; Li PC; Yue JR
Medicine (Baltimore); 2024 Feb; 103(5):e37067. PubMed ID: 38306560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
